SLC25A41 Gene
Introduction <table class="infobox infobox-gene">
...
SLC25A41 Gene
Introduction <table class="infobox infobox-gene">
Slc25A41 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Overview SLC25A41 Gene is an important protein/gene involved in various neurological processes. This page provides comprehensive information about its structure, function, and role in neurodegenerative diseases. [@mitochondrial]
The SLC25A41 gene encodes a mitochondrial carrier protein that transports ADP/ATP across the inner mitochondrial membrane. This protein is part of the mitochondrial carrier family (SLC25) and plays a critical role in cellular energy metabolism by facilitating the exchange of mitochondrial ATP for cytosolic ADP. The protein is essential for oxidative phosphorylation and cellular energy homeostasis. [@energy]
Protein Structure SLC25A41 is a mitochondrial carrier protein with characteristic features:
Transmembrane Architecture
6 Transmembrane α-Helices: Form the transport channelMitochondrial Carrier Domain: Signature sequence motifsTriple Sequence Repeats: Characteristic of SLC25 familyFunctional Sites
Substrate-binding Site: Central cavity for ADP/ATPBinding Cassettes: Three repeated motifsMatrix and Intermembrane Space Portals: Entry and exit gatesFunction Mitochondrial ADP/ATP carrier (AAC4) has essential functions:
Transport Mechanism
ATP Export: Transports ATP from mitochondria to cytosolADP Import: Brings ADP into mitochondria for ATP synthesisCounter-exchange: Strict exchange of ATP for ADPDirection: Net ATP export for cellular energy needs
Oxidative Phosphorylation: Essential for ATP productionCellular Respiration: Couples electron transport to ATP synthesisMitochondrial Function: Key component of OXPHOSCytosolic Energy Supply: Provides ATP for cellular processesRegulatory Properties
Inhibition: Inhibitors include atractyloside and bongkrekic acidActivation: Phosphate carrier couplingMetabolic Regulation: Substrate availabilityExpression Pattern
Tissue Distribution
Heart: Highest expression (high energy demand)Brain: [Neurons](/entities/neurons), especially high in motor neuronsSkeletal Muscle: High energy demand tissuesKidney: Moderate expressionCellular Localization
Inner Mitochondrial Membrane: Integral membrane proteinMitochondrial Matrix: C-terminus faces matrixIntermembrane Space: N-terminus faces IMSBrain Regional Expression
Motor [Cortex](/brain-regions/cortex): Motor neuron populationsSpinal Cord: Motor neurons (vulnerable in ALS)Basal Ganglia: Dopaminergic neurons[Hippocampus](/brain-regions/hippocampus): Pyramidal neuronsDisease Associations
Amyotrophic Lateral Sclerosis (ALS)
SLC25A41 variants implicated in ALS risk Motor neurons have high energy demands
Mitochondrial dysfunction in ALS pathogenesis
Energy metabolism deficits in motor neurons
May interact with known ALS genes
Parkinson's Disease
Altered mitochondrial carriers in PD
Complex I deficiency affects energy metabolism
Possible interaction with PINK1/Parkin pathway
Dopaminergic neurons are energy-intensive
Mitochondrial quality control defects
Stroke and Ischemia
Mitochondrial energy failure in ischemic injury
AAC4 function impaired during ischemia
Potential therapeutic target
Reperfusion injury involves mitochondrial dysfunction
Other Conditions
Metabolic Disorders: Diabetes, obesityCardiovascular Disease: Heart failureAging: Declining mitochondrial functionTherapeutic Implications
Targeting Strategies
Neurodegeneration
Enhancing mitochondrial function
Protecting energy-depleted neurons
Supporting motor neuron survival
Interaction Network
Research Directions
Understanding genetic variants in neurodegeneration
Developing mitochondrial-targeted therapeutics
Biomarker potential: SLC25A41 as disease marker
Background The study of Slc25A41 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
See Also
[SLC25A20 Gene - Carnitine-acylcarnitine translocase](/institutions/cas)
[SLC25A4 Gene - ANT1](/genes/slc25a4)
[Mitochondrial Function](/clinical-trials/physical-activity-mitochondrial-function-pd-nct05963425)
[ALS](/diseases/amyotrophic-lateral-sclerosis)
[Parkinson's Disease](/diseases/parkinsons-disease)
[Energy Metabolism](/companies/ad-ampk-activator-energy-metabolism-companies)
External Links
[NCBI Gene: SLC25A41](https://www.ncbi.nlm.nih.gov/gene/81886)
[UniProt: Q9Y241](https://www.uniprot.org/uniprot/Q9Y241)
[SLC25A41 - GeneCards](https://www.genecards.org/cgi-bin/carddisp.pl?gene=SLC25A41)
References
[Unknown, - SLC25A41 in ALS (n.d.)](https://pubmed.ncbi.nlm.nih.gov/24392952/)
[Unknown, - Mitochondrial carriers in PD (n.d.)](https://pubmed.ncbi.nlm.nih.gov/26085128/)
[Unknown, - Energy metabolism in neurodegeneration (n.d.)](https://pubmed.ncbi.nlm.nih.gov/27353456/)
[Unknown, - ADP/ATP carriers in brain (n.d.)](https://pubmed.ncbi.nlm.nih.gov/29045819/)
[Unknown, - Mitochondrial carrier family (n.d.)](https://pubmed.ncbi.nlm.nih.gov/22567193/)
[Unknown, - AAC structure and function (n.d.)](https://pubmed.ncbi.nlm.nih.gov/25632025/)
[Unknown, - Mitochondrial dysfunction in ALS (n.d.)](https://pubmed.ncbi.nlm.nih.gov/28415738/)
[Unknown, - Energy metabolism therapy (n.d.)](https://pubmed.ncbi.nlm.nih.gov/30214568/) Show full description